Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93913993 | 9391399 | 3 | F | 20160908 | 20130709 | 20160915 | EXP | CN-ASTELLAS-2013US006995 | ASTELLAS | WU S, LUO H, WANG L, ZHANG X, XIA B, XIE C ET AL. PHASE III RANDOMIZED STUDY OF ELECTIVE NODAL IRRADIATION PLUS ERLOTINIB COMBINED WITH CHEMOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA [ABS 4048].. JOURNAL OF CLINICAL ONCOLOGY. 2016;34(SUPP 15):NO INFORMATION | 66.00 | YR | M | Y | 0.00000 | 20160915 | CN | GB | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93913993 | 9391399 | 1 | PS | Erlotinib | ERLOTINIB | 1 | Oral | U | 21743 | 150 | MG | TABLET | QD | ||||||
| 93913993 | 9391399 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | 20 MG/M2, DAY 1-3, EVERY 4 WEEKS FOR 2 CYCLES | U | 0 | 20 | MG/M**2 | FORMULATION UNKNOWN | ||||||
| 93913993 | 9391399 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 135 MG/M2, DAY 1 EVERY 4 WEEKS FOR 2 CYCLES | U | 0 | 135 | MG/M**2 | FORMULATION UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93913993 | 9391399 | 1 | Oesophageal squamous cell carcinoma |
| 93913993 | 9391399 | 2 | Oesophageal squamous cell carcinoma |
| 93913993 | 9391399 | 3 | Oesophageal squamous cell carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93913993 | 9391399 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93913993 | 9391399 | Gastrointestinal toxicity | |
| 93913993 | 9391399 | Haematotoxicity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |